Ignite Creation Date:
2024-05-06 @ 7:16 PM
Last Modification Date:
2024-10-26 @ 3:03 PM
Study NCT ID:
NCT05954442
Status:
RECRUITING
Last Update Posted:
2024-01-16
First Post:
2023-07-13
Brief Title:
Everolimus With Investigators Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer TNBC With Luminal Androgen Receptor LAR Subtype
Sponsor:
Fudan University
Organization:
Fudan University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-13
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-08
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-13
First Submit QC Date:
July 13 2023
Study First Post Date:
2023-07-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-12
Last Update Post Date:
2024-01-16
Last Update Post Date Type:
ACTUAL